Trial of Iloprost in Pulmonary Hypertension Secondary to Pulmonary Fibrosis - Related Studies

Trial of Iloprost in Pulmonary Hypertension Secondary to Pulmonary Fibrosis

This study is not yet open for participant recruitment.

Study NCT00439543. Last updated on February 22, 2007. Information provided by Interstitial Lung Disease Study Group, Korea

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:


1	Conditions listed in this trial
		Pulmonary Fibrosis
		Pulmonary Hypertension

2	Additional conditions recognized in this trial
		Fibrosis
		Hypertension
		Hypertension, Pulmonary

3	More general conditions related to this trial
		Cardiovascular Diseases
		Lung Diseases
		Lung Diseases, Interstitial
		Pathologic Processes
		Respiratory Tract Diseases
		Vascular Diseases

4	Interventions listed in this trial
		Iloprost inhalation

5	Additional drug interventions recognized in this trial
		Iloprost

6	More general drug interventions related to this trial
		Cardiovascular Agents
		Hematologic Agents
		Pharmacologic Actions
		Platelet Aggregation Inhibitors
		Therapeutic Uses
		Vasodilator Agents

7	Sponsors listed in this trial
		Interstitial Lung Disease Study Group, Korea